“After struggling to fund COVID research through traditional philanthropy, musician Aloe Blacc discovered the complexities of biotech commercialization and is now bootstrapping a cancer drug platform. This highlights how domain expertise from outside tech isn't enough—biotech requires navigating regulatory frameworks and clinical trials that traditional funding models don't support.”